Clinical Trials Logo
  1. Home
  2. Carotid Artery Disease
  3. NCT00402740

Protected Carotid Artery Stenting in Subjects at High Risk for Carotid Endarterectomy (CEA) (PROTECT) — PROTECT  

Carotid Artery Disease Clinical Trial

Official title:
Protected Carotid Artery Stenting in Subjects at High Risk for Carotid Endarterectomy (CEA)

Clinical Trial Summary

The purpose of this study is to evaluate the long-term safety and efficacy of the Xact™ Rapid Exchange Carotid Stent System used in conjunction with the Emboshield® Pro Rapid Exchange Embolic Protection System (Generation 5) and the Emboshield® BareWire™ Rapid Exchange Embolic Protection System (Generation 3), in the treatment of atherosclerotic carotid artery disease in high-surgical risk subjects.

Clinical Trial Description

n/a

Study Design

Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT00402740
Study type Interventional
Source Abbott Vascular
Contact
Status Completed
Phase N/A
Start date November 2006
Completion date October 2011
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT02124928 - Morphological and Serological Criteria of Plaque Vulnerability: Risk Assessment for Symptomatic and Asymptomatic Carotid Artery Stenosis N/A
Active, not recruiting NCT01597453 - NOR-SYS: The Norwegian Stroke in the Young Study N/A
Completed NCT00744523 - Proximal Protection With The Mo.Ma Device During Carotid Stenting N/A
Completed NCT00231231 - Carotid Artery Stenting With Emboli Protection Surveillance-Post-Marketing Study (CASES-PMS) Phase 3
Completed NCT00597974 - Neurological Outcome With Carotid Artery Stenting N/A
Completed NCT00587717 - The Acute Effect of Statins on Inflammatory Markers of Athersclerotic Tissue N/A
Completed NCT02536378 - POST-APPROVAL STUDY of TRANSCAROTID ARTERY REVASCULARIZATION in PATIENTS With SIGNIFICANT CAROTID ARTERY DISEASE
Completed NCT02126982 - Salts of Clopidogrel: Investigation to ENsure Clinical Equivalence
Active, not recruiting NCT01445613 - Carotid Artery Stenting Outcomes in the Standard Risk Population for Carotid Endarterectomy N/A
Terminated NCT01414387 - Effects of Cerebral Protection With Filters vs. Flow Reversal on Cerebral Embolization After Carotid Artery Stenting N/A
Completed NCT00403078 - SAPPHIRE Worldwide: Stenting and Angioplasty With Protection in Patients At High-Risk for Endarterectomy
Completed NCT00406055 - CHOICE: Carotid Stenting For High Surgical-Risk Patients Phase 4
Terminated NCT01968226 - TRACER RGD-K5 Carotid Plaque Imaging Study Phase 2
Completed NCT01685567 - Safety and Efficacy Study for Reverse Flow Used During Carotid Artery Stenting Procedure Phase 3
Completed NCT00287508 - Emboshield® and Xact® Post Approval Carotid Stent Trial (The EXACT Study) Phase 4
Completed NCT00178672 - A Single Center of Carotid Stenting With Distal Protection for the Treatment of Obstructive Carotid Artery Disease Phase 4
Recruiting NCT02850588 - SVS VQI TransCarotid Revascularization Surveillance Project
Completed NCT02759653 - Norwegian Carotid Plaque Study
Withdrawn NCT01042912 - Frequency Analysis of Carotid Artery Disease N/A
Completed NCT00530504 - Carotid Revascularization With ev3 Arterial Technology Evolution Post Approval Study N/A